Skip to Content
  • Previous Rank
    8
  • Revenue 3 Yr Annual Growth Rate
    36%
  • Revenue 3 Yr Growth Rank
    37
  • EPS 3 Yr Annual Growth Rate
    88%
  • EPS 3 Yr Growth Rank
    11
  • Total Return 3 Yr Annual Rate
    79%
  • Total Return 3 Yr Rank
    4

Maker of the first artificial heart, Abiomed’s revenues have been racing on sales of the Impella heart pump for patients with heart failure, a growing market.

Company Information

Revenue and net income for the four quarters ended on or before April 30, 2017. Total return for the period ended June 30, 2017.
Location
Danvers, Mass.
Industry
Medical Products & Equipment
Sector
Health Care
Current Streak3
Years on List3
CEO
Michael Minogue
Websitehttp://www.abiomed.com

Revenue, Net Income

Revenue past four quarters ($M)$445
Net Income past four quarters ($M)$52

Growth Rates and Ranks

Revenue 3 Yr Growth Rank37
Revenue 3 Yr Annual Growth Rate36%
EPS 3 Yr Growth Rank11
EPS 3 Yr Annual Growth Rate88%
Total Return 3 Yr Rank4
Total Return 3 Yr Annual Rate79%
Beat S&P 500 (9.6%)
yes
P/E Ratio66